Drug profile · INN
sutilains
TRAVASE
sutilains (TRAVASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Drug details — sutilains
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sutilains (TRAVASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is sutilains?
sutilains (TRAVASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for sutilains?
TRAVASE is a marketed brand name for sutilains. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sutilains?
sutilains has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.